Annual Current Assets
$236.21 M
-$39.67 M-14.38%
31 December 2023
Summary:
Monte Rosa Therapeutics annual total current assets is currently $236.21 million, with the most recent change of -$39.67 million (-14.38%) on 31 December 2023. During the last 3 years, it has risen by +$192.62 million (+441.88%). GLUE annual current assets is now -32.25% below its all-time high of $348.67 million, reached on 31 December 2021.GLUE Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$251.21 M
-$26.69 M-9.60%
30 September 2024
Summary:
Monte Rosa Therapeutics quarterly total current assets is currently $251.21 million, with the most recent change of -$26.69 million (-9.60%) on 30 September 2024. Over the past year, it has increased by +$68.30 million (+37.34%). GLUE quarterly current assets is now -32.20% below its all-time high of $370.52 million, reached on 30 September 2021.GLUE Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GLUE Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -14.4% | +37.3% |
| 3 y3 years | +441.9% | -32.2% |
| 5 y5 years | - | - |
GLUE Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -32.3% | +441.9% | -32.2% | +37.3% |
| 5 y | 5 years | -32.3% | +2320.4% | -32.2% | +476.3% |
| alltime | all time | -32.3% | +2320.4% | -32.2% | +476.3% |
Monte Rosa Therapeutics Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $251.21 M(-9.6%) |
| June 2024 | - | $277.90 M(+39.6%) |
| Mar 2024 | - | $199.04 M(-15.7%) |
| Dec 2023 | $67.54 M(+1.6%) | $236.21 M(+29.1%) |
| Sept 2023 | - | $182.91 M(-12.1%) |
| June 2023 | - | $208.10 M(-13.5%) |
| Mar 2023 | - | $240.56 M(-12.8%) |
| Dec 2022 | $66.50 M | $275.89 M(-6.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $295.24 M(-0.6%) |
| June 2022 | - | $297.05 M(-7.3%) |
| Mar 2022 | - | $320.37 M(-8.1%) |
| Dec 2021 | $17.66 M(+205.2%) | $348.67 M(-5.9%) |
| Sept 2021 | - | $370.52 M(+3.4%) |
| June 2021 | - | $358.29 M(+108.7%) |
| Mar 2021 | - | $171.71 M(+293.9%) |
| Dec 2020 | $5.79 M(+333.5%) | $43.59 M |
| Dec 2019 | $1.33 M | - |
FAQ
- What is Monte Rosa Therapeutics annual total current assets?
- What is the all time high annual current assets for Monte Rosa Therapeutics?
- What is Monte Rosa Therapeutics annual current assets year-on-year change?
- What is Monte Rosa Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Monte Rosa Therapeutics?
- What is Monte Rosa Therapeutics quarterly current assets year-on-year change?
What is Monte Rosa Therapeutics annual total current assets?
The current annual current assets of GLUE is $236.21 M
What is the all time high annual current assets for Monte Rosa Therapeutics?
Monte Rosa Therapeutics all-time high annual total current assets is $348.67 M
What is Monte Rosa Therapeutics annual current assets year-on-year change?
Over the past year, GLUE annual total current assets has changed by -$39.67 M (-14.38%)
What is Monte Rosa Therapeutics quarterly total current assets?
The current quarterly current assets of GLUE is $251.21 M
What is the all time high quarterly current assets for Monte Rosa Therapeutics?
Monte Rosa Therapeutics all-time high quarterly total current assets is $370.52 M
What is Monte Rosa Therapeutics quarterly current assets year-on-year change?
Over the past year, GLUE quarterly total current assets has changed by +$68.30 M (+37.34%)